Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy (2021)
- Authors:
- Vigón, Lorena
- Román, Paula Martínez
- Mora, Sara Rodríguez
- Torres, Montserrat
- Puertas, María C
- Mateos, Elena
- Salgado, María
- Navarro, Antonio
- Conde, Matilde Sánchez
- Ambrosioni, Juan
- Cervero, Miguel
- Wyen, Christoph
- Hoffmann, Christoph M.
- Miró, José M
- Alcamí, José
- Podzamczer, Daniel
- Gutiérrez, Valentín García
- Picado, Javier Martínez
- Briz, Verónica
- Huertas, María Rosa López
- Planelles, Vicente
- Coiras, Mayte
- Autor USP: HOFFMANN, CHRISTIAN - FCF
- Unidade: FCF
- DOI: 10.1016/j.bcp.2021.114666
- Subjects: HIV; ANTIRRETROVIRAIS; ADJUVANTES IMUNOLÓGICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2021
- Source:
- Título do periódico: Biochemical Pharmacology
- ISSN: 0006-2952
- Volume/Número/Paginação/Ano: v. 192, p. 1-34 art. 114666, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
VIGÓN, Lorena et al. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, v. 192, p. 1-34 art. 114666, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114666. Acesso em: 14 maio 2024. -
APA
Vigón, L., Román, P. M., Mora, S. R., Torres, M., Puertas, M. C., Mateos, E., et al. (2021). Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, 192, 1-34 art. 114666. doi:10.1016/j.bcp.2021.114666 -
NLM
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2024 maio 14 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666 -
Vancouver
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2024 maio 14 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666 - Comparison of gut microbiota composition between peritoneal dialysis patients and healthy household contacts
- Lung Epithelial CYP1 activity regulates aryl hydrocarbon receptor dependent allergic airway inflammation
- Enterótipos: interesse e aplicações
- Diet quality components and gut microbiota of peritoneal dialysis patients
- Probiotics for obesity and metabolic syndrome prevention and treatment
- População Ribeirinha do Rio Solimões na Amazônia brasileira apresenta uma microbiota oral da placa supragengival característica e correlacionada com a dieta
- Gut microbiota is associated with adiposity markers and probiotics may impact specific genera
- Gut microbiota profile of patients on peritoneal dialysis: comparison with household contacts
- Bioinformatic analysis of the effect of oral beta-glucan on gut microbiome
- Immunomodulatory activity of β-glucan-containing exopolysaccharides from Auricularia auricular in phagocytes and mice infected with Cryptococcus neoformans
Informações sobre o DOI: 10.1016/j.bcp.2021.114666 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3052875.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
